合計 50 件の最近のインサイダー取引記録が記録されています Cadrenal Therapeutics, Inc. Common Stock (CVKD), 内訳は 22 件の買い および 24 件の売り. インサイダー買い総額は $7.95M インサイダー売り総額は $850.81K.
最近活動のある主要インサイダーには Szot Matthew K, Golden Lee Scott, Pham Quang X. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — CVKD
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2025-12-29 |
Szot Matthew K |
Chief Financial Officer |
情報に基づく売り |
9,933 |
$6.97 |
$69.23K |
- |
| 2025-12-02 |
Golden Lee Scott |
Director |
RSU 付与（制限付株式） |
5,000 |
$8.27 |
$41.35K |
5,000 |
| 2025-11-24 |
Golden Lee Scott |
Director |
不明 |
- |
- |
- |
1,667 |
| 2025-10-27 |
Szot Matthew K |
Chief Financial Officer |
情報に基づく売り |
1,800 |
$13.99 |
$25.18K |
9,933 |
| 2025-10-27 |
Pham Quang X |
10 Percent Owner, Officer: CEO and Chairman |
情報に基づく売り |
1,315 |
$13.99 |
$18.4K |
196,089 |
| 2025-10-24 |
Szot Matthew K |
Chief Financial Officer |
情報に基づく売り |
1,800 |
$13.99 |
$25.18K |
11,733 |
| 2025-10-24 |
Pham Quang X |
10 Percent Owner, Officer: CEO and Chairman |
情報に基づく売り |
1,129 |
$14.03 |
$15.84K |
197,404 |
| 2025-10-13 |
Szot Matthew K |
Chief Financial Officer |
情報に基づく売り |
1,800 |
$14.07 |
$25.33K |
13,533 |
| 2025-10-13 |
Pham Quang X |
10 Percent Owner, Officer: CEO and Chairman |
情報に基づく売り |
1,800 |
$14.15 |
$25.47K |
198,533 |
| 2025-10-09 |
Szot Matthew K |
Chief Financial Officer |
情報に基づく売り |
1,693 |
$13.99 |
$23.69K |
15,333 |
| 2025-10-09 |
Pham Quang X |
10 Percent Owner, Officer: CEO and Chairman |
情報に基づく売り |
1,800 |
$14.02 |
$25.24K |
200,333 |
| 2025-10-06 |
Szot Matthew K |
Chief Financial Officer |
情報に基づく売り |
107 |
$13.99 |
$1.5K |
17,026 |
| 2025-10-02 |
Pham Quang X |
10 Percent Owner, Officer: CEO and Chairman |
情報に基づく売り |
500 |
$14.13 |
$7.07K |
202,133 |
| 2025-10-01 |
Szot Matthew K |
Chief Financial Officer |
情報に基づく売り |
1,700 |
$13.99 |
$23.78K |
17,133 |
| 2025-10-01 |
Pham Quang X |
10 Percent Owner, Officer: CEO and Chairman |
情報に基づく売り |
881 |
$14.01 |
$12.34K |
202,633 |
| 2025-09-29 |
Szot Matthew K |
Chief Financial Officer |
情報に基づく売り |
100 |
$14.00 |
$1.4K |
18,833 |
| 2025-09-29 |
Pham Quang X |
10 Percent Owner, Officer: CEO and Chairman |
情報に基づく売り |
419 |
$14.01 |
$5.87K |
203,514 |
| 2025-09-25 |
Szot Matthew K |
Chief Financial Officer |
情報に基づく売り |
10,900 |
$14.05 |
$153.18K |
18,933 |
| 2025-09-25 |
Pham Quang X |
10 Percent Owner, Officer: CEO and Chairman |
情報に基づく売り |
6,790 |
$14.09 |
$95.67K |
203,933 |
| 2025-09-24 |
Szot Matthew K |
Chief Financial Officer |
情報に基づく売り |
1,500 |
$14.00 |
$20.99K |
29,833 |
| 2025-09-24 |
Pham Quang X |
10 Percent Owner, Officer: CEO and Chairman |
情報に基づく売り |
2,581 |
$13.99 |
$36.11K |
210,723 |
| 2025-08-28 |
Szot Matthew K |
Chief Financial Officer |
情報に基づく売り |
400 |
$14.00 |
$5.6K |
31,333 |
| 2025-08-28 |
Pham Quang X |
10 Percent Owner, Officer: CEO and Chairman |
情報に基づく売り |
1,193 |
$13.99 |
$16.69K |
213,304 |
| 2025-08-27 |
Szot Matthew K |
Chief Financial Officer |
情報に基づく売り |
1,600 |
$14.00 |
$22.39K |
31,733 |
| 2025-08-27 |
Pham Quang X |
10 Percent Owner, Officer: CEO and Chairman |
情報に基づく売り |
3,836 |
$13.99 |
$53.67K |
214,497 |
| 2025-02-05 |
Ferguson James J. Iii |
Officer |
不明 |
- |
- |
- |
- |
| 2025-02-05 |
Ferguson James J. Iii |
Chief Medical Officer |
RSU 付与（制限付株式） |
60,000 |
$19.75 |
$1.19M |
60,000 |
| 2025-02-01 |
Cole Jeffrey Scott |
Chief Operating Officer |
処分 |
150,000 |
$0.94 |
$141K |
- |
| 2025-01-23 |
Murphy John Raymond |
Director |
RSU 付与（制限付株式） |
20,000 |
$19.79 |
$395.8K |
20,000 |
| 2025-01-23 |
Szot Matthew K |
Chief Financial Officer |
RSU 付与（制限付株式） |
50,000 |
$19.79 |
$989.5K |
50,000 |
| 2025-01-23 |
Pham Quang X |
10 Percent Owner, Officer: CEO and Chairman |
RSU 付与（制限付株式） |
65,000 |
$21.77 |
$1.41M |
65,000 |
| 2025-01-23 |
Wilson Glynn |
Director |
RSU 付与（制限付株式） |
20,000 |
$19.79 |
$395.8K |
20,000 |
| 2025-01-23 |
Zelenkofske Steven |
Director |
RSU 付与（制限付株式） |
20,000 |
$19.79 |
$395.8K |
20,000 |
| 2025-01-23 |
Cole Jeffrey Scott |
Chief Operating Officer |
RSU 付与（制限付株式） |
25,000 |
$19.79 |
$494.75K |
25,000 |
| 2025-01-23 |
Lisicki Robert |
Director |
RSU 付与（制限付株式） |
20,000 |
$19.79 |
$395.8K |
20,000 |
| 2025-01-23 |
Pham Quang X |
10 Percent Owner, Officer: CEO and Chairman |
RSU 付与（制限付株式） |
65,000 |
$19.79 |
$1.29M |
65,000 |
| 2024-04-10 |
Pham Quang X |
10 Percent Owner, Officer: CEO and Chairman |
贈与（送付） |
50,000 |
- |
- |
3,275,000 |
| 2024-04-02 |
Cole Jeffrey Scott |
Chief Operating Officer |
RSU 付与（制限付株式） |
150,000 |
$0.62 |
$93K |
150,000 |
| 2024-01-18 |
Murphy John Raymond |
Director |
RSU 付与（制限付株式） |
100,000 |
$0.94 |
$94K |
100,000 |
| 2024-01-18 |
Szot Matthew K |
Chief Financial Officer |
RSU 付与（制限付株式） |
250,000 |
$0.94 |
$235K |
250,000 |
| 2024-01-18 |
Pham Quang X |
10 Percent Owner, Officer: Chief Executive Officer |
RSU 付与（制限付株式） |
150,000 |
$0.94 |
$141K |
150,000 |
| 2024-01-18 |
Wilson Glynn |
Director |
RSU 付与（制限付株式） |
70,000 |
$0.94 |
$65.8K |
70,000 |
| 2024-01-18 |
Zelenkofske Steven |
Director |
RSU 付与（制限付株式） |
100,000 |
$0.94 |
$94K |
100,000 |
| 2024-01-18 |
Losordo Douglas W |
Chief Medical Officer |
RSU 付与（制限付株式） |
150,000 |
$0.94 |
$141K |
150,000 |
| 2024-01-18 |
Lisicki Robert |
Director |
RSU 付与（制限付株式） |
50,000 |
$0.94 |
$47K |
50,000 |
| 2023-10-23 |
Pham Quang X |
10 Percent Owner, Officer: CEO and Chairman |
贈与（送付） |
85,000 |
- |
- |
3,325,000 |
| 2023-10-05 |
Murphy John Raymond |
Director |
情報に基づく買い |
2,669 |
$0.69 |
$1.84K |
614,792 |
| 2023-10-04 |
Murphy John Raymond |
Director |
情報に基づく買い |
17,331 |
$0.70 |
$12.13K |
612,123 |
| 2023-09-05 |
Pham Quang X |
10 Percent Owner, Officer: CEO and Chairman |
情報に基づく買い |
20,000 |
$0.91 |
$18.2K |
3,390,000 |
| 2023-09-01 |
Pham Quang X |
10 Percent Owner, Officer: CEO and Chairman |
情報に基づく買い |
10,000 |
$0.93 |
$9.32K |
3,310,000 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
